|
adenosine: First Dose (0.1 mg/kg)
|
|
3 mg/mL |
|
|
Maximum: 6 mg/dose. IV over 1 second, flush with at least 5 mL of sodium chloride 0.9%. Give at IV site closest to heart. Only give IO if no IV access.
|
|
adenosine: Repeat Dose (0.2 mg/kg)
|
|
3 mg/mL |
|
|
Maximum: 12 mg/dose. IV over 1 second, flush with at least 5 mL sodium chloride 0.9%. Give at IV site closest to heart. Only give IO if no IV access.
|
|
amiodarone: Pulseless VF/VT (5 mg/kg)
|
|
50 mg/mL |
|
|
Maximum: 300 mg/dose. For cardiac arrest, IV/IO over 1–2 seconds. May repeat up to 3 times.
|
| amiodarone: SVT/VT with Pulse (5 mg/kg) |
|
6 mg/mL |
( of 50 mg/mL + D5W) |
|
Supplied as 50 mg/mL. Must be diluted to 6 mg/mL. Maximum: 300 mg/dose. IV/IO over 20–60 minutes.
|
| atropine (0.02 mg/kg) **using 0.2 mg/mL syringe** |
|
0.2 mg/mL |
|
|
Maximum: 0.5 mg/dose. IV/IO over 1 minute.
|
| calcium chloride (20 mg/kg) |
|
100 mg/mL |
|
|
Maximum: 1000 mg/dose. IV/IO over 10–20 seconds. May repeat as needed.
|
| EPINEPHrine (0.01 mg/kg) |
|
0.1 mg/mL |
|
|
Maximum 1 mg/dose. IV/IO over 1–2 seconds. May repeat every 3 to 5 min.
|
| dextrose (D50W) (0.5 g–1 g/kg) |
|
0.5 g/mL |
|
|
Maximum: 25 g/dose. IV/IO (central line preferred) over 2–3 minutes.
|
| magnesium sulfate: Pulseless VT (25–50 mg/kg) |
|
200 mg/mL |
|
|
Maximum: 2000 mg/dose. IV/IO over seconds.
|
| naloxone (0.1 mg/kg) IV/IO/IM |
|
0.4 mg/mL |
|
|
Maximum: 2 mg/dose. 0.1 mg/kg/dose IV/IO over seconds, may repeat doses q2mins to effect.
|
| sodium bicarbonate (1 mmol/kg) |
|
1 mmol/mL |
|
|
Maximum: 100 mmol/dose. IV/IO over 2 minutes.
|
Anaphylaxis Medications
|
| Drug |
Dose |
Concentration |
Volume |
| EPINEPHrine (0.01 mg/kg) IM |
|
1 mg/mL |
|
|
Maximum: 0.5 mg/dose. Intramuscular.
|